Clinical Challenges and Renal Considerations In Managing Gout
A case study examines the treatment of hyperuricemia and gout in a 57-year-old postmenopausal renal transplant recipient with intermittent gout attacks.
Print Issue: March 01, 2012
Target-Date Funds Enable Investors to Own a Diverse Portfolio
The fund you should pick depends on your tolerance for volatility. Either aggressive or cautious funds can work. Pick one that suits your temperament.
Lessons from “The Hemodialysis Marathon Man”
An impressive story of a dialysis survivor who watched his daughters grow and getting married, and had the joy of knowing several grandchildren.
PSMs Predict PCa Recurrence in Some Men
Positive surgical margins (PSMs) are a risk factor for biochemical recurrence of prostate cancer (PCa) in patients who have undergone radical prostatectomy for intermediate-risk disease.
Unusual Manifestation of an Aldosterone-Producing Adenoma
Primary aldosteronism was first described by Jerome Conn in 1955 in a patient with an aldosterone-producing adrenal adenoma. It’s now a widely recognized cause of secondary hypertension.
Resistant Hypertension Secondary to Primary Aldosteronism
A 43-year-old man was evaluated for uncontrolled hypertension (HTN) despite multiple drug therapy, which included amlodipine 10 mg daily, clonidine 0.3 mg BID, and metoprolol XL 200 mg BID.
Health Care Workers Should Promote Dietary Salt Reduction
Historically, salt has been a commodity, a preservative, and a flavor enhancer. The salt shaker has a special place in most kitchens or dining room tables.
Vytorin Label Will Include Kidney Data
The FDA has approved new labeling for the cardiovascular agent Vytorin (ezetimibe/simvastatin) that will include data from the Study of Heart and Renal Protection (SHARP).
Adverse RP Effects Not Lessened with Robotics
Patients undergoing prostate cancer surgery will face similar risks for incontinence and sexual problems whether they undergo robotic-assisted laparoscopic radical prostectomy (RP) or open RP.
Renal Decline Linked to TNF Receptors
High levels of tumor necrosis factor (TNF) receptors 1 and 2 are associated with an increased risk of kidney disease in patients with type 1 diabetes.
